Researchers from the European League Against Rheumatism (EULAR) have published a list of recommendations that women with lupus or antiphospholipid syndrome (APS) can use to deal with health issues or do family planning. The article, “EULAR Recommendations For Women’s Health And The Management Of Family Planning, Assisted Reproduction, Pregnancy And…
The results of a Phase 2/3 trial at two hospitals in the U.K. comparing the effectiveness of Xarelto (rivaroxaban) and Coumadin (warfarin) in the treatment of patients with thrombotic antiphospholipid syndrome (APS), with or without systemic lupus erythematosus, showed that Xarelto can be a safe and effective option for patients with…
During the recent European League Against Rheumatism Annual Congress (EULAR 2015) that took place June 11-13 in Rome, Italy, new clinical recommendations for patients with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS) who are trying to conceive or are currently pregnant were presented by the league. These new recommendations…